pulmonary-fibrosis

Documents about pulmonary-fibrosis

• PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial#1031101ClinicalTrials.gov
• Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19#1008238ClinicalTrials.gov
• Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis#911793ClinicalTrials.gov
• Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients#829859ClinicalTrials.gov
• Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis#836518ClinicalTrials.gov
• Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase#872852ClinicalTrials.gov
• Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations#804364ClinicalTrials.gov
• Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis#1046410ClinicalTrials.gov
• PROOF-Registry New and Extended Belgium -Luxembourg#829665ClinicalTrials.gov
• Machine Learning Prediction of Pulmonary Function in Children With Cystic Fibrosis#1030420ClinicalTrials.gov
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease#184722ClinicalTrials.gov
• Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences#804778ClinicalTrials.gov
• Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole#842339ClinicalTrials.gov
• An analysis of an Ising-like agent based model of lung inflammation and fibrosis in response to particulate matter using a Netlogo v6.0 platform#194158Animo Repository
• RHEology of the Pulmonary MUcus#812722ClinicalTrials.gov
• Immunopathologic Profiles and Blood Biomarkers in Patients With IPF#902209ClinicalTrials.gov
• A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)#827320ClinicalTrials.gov
• Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis#826757ClinicalTrials.gov
• Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis#850820ClinicalTrials.gov
• Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis#1045234ClinicalTrials.gov
• Effects of Inspiratory Muscle Training on Postural Stability, Balance, Pulmonary Function and Functional Capacity in Children With Cystic Fibrosis#871913ClinicalTrials.gov
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.#1030220ClinicalTrials.gov
• Pharmacological inhibition of Epac1 protects against pulmonary fibrosis by blocking FoxO3a neddylation#8157HAL (France)
• Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease: A Comprehensive Analysis#417310AVESIS
• All-Case Surveillance of Ofev in Patients With IPF in Japan#803516ClinicalTrials.gov
• Microscopy Image Dataset of pulmonary vessels for Quantitative assessment of fibrosis#818489HAL (France)
• Accuracy of Spircare Device as Compared to the Conventional Plethysmograph#1030469ClinicalTrials.gov
• Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD#967554ClinicalTrials.gov
• Deletion of STIM1 in Treg Cells Protects Against Lung Fibrosis and Associated Cardiovascular Complications in a Pre-Clinical Mouse Model#169477ODU Digital Commons
• Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis#804437ClinicalTrials.gov
• Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis#812432ClinicalTrials.gov
• Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa#885980ClinicalTrials.gov
• First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects#474841ClinicalTrials.gov
• Recognizing the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, and for other purposes.#128935Congress.gov
• Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT#841710ClinicalTrials.gov
• A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications#856482ClinicalTrials.gov
• Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen#850374ClinicalTrials.gov
• Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants#222358bioRxiv / medRxiv
• Formononetin ameliorates bleomycin-induced pulmonary fibrosis in mice via targeting USP5.#685832NCBI PubMed Central
• Efficacy of Osteopathic Manipulative Techniques With Progressive Pulmonary Fibrosis Patients#813231ClinicalTrials.gov
• Increased Vitamin D Reduces Pulmonary Exacerbations in CF#872273ClinicalTrials.gov
• A Trial of SHR - 1906 in Healthy Subjects#1029816ClinicalTrials.gov
• Lineage tracing of alveolar fibroblasts during delayed resolution of pulmonary fibrosis in aged mice#1066585JLUpub
• Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases#870791ClinicalTrials.gov
• Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis#912547ClinicalTrials.gov
• New Diagnostic Approaches in the Management of Inflammatory Lung Diseases#887839ClinicalTrials.gov
• Medication Adherence and Non-adherence in Adults With Rare Disease#909803ClinicalTrials.gov
• Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative study.#315441NCBI PubMed Central
• STARSHIP: Study of Telomeres And Role of Sex Hormones In Pulmonary fibrosis#475697Europe PMC
• Impact of Availability of Showerpatch for Patients With Intravenous Catheters#682978ClinicalTrials.gov